Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00321022 · ClinicalTrials.gov registry record · NA
Transient Ischemic Attack (TIA) Accelerated Diagnostic Protocol
A NA study of Transient Ischemic Attack, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
- 1
- Study location
NCT00321022: Completed NA study of Transient Ischemic Attack, sponsored by Corewell Health East.
NCT00321022 is a NA study of Transient Ischemic Attack that has completed, run by Corewell Health East. The registered enrollment target is 154 participants, below the 1,112-participant average among 7 other Transient Ischemic Attack trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00321022, a NA study of Transient Ischemic Attack, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine if emergency department patients with Transient Ischemic Attack (TIA) that are managed using a TIA "accelerated diagnostic protocol", or "ADP", demonstrate a significant decrease in their index visit length of stay and cost, with comparable diagnostic and 90-day clinical outcomes relative to TIA patients randomized to traditional inpatient care. The secondary objectives are to evaluate the potential role of a TIA risk stratification tool and to determine the time to a diagnostic endpoint in both groups.
Conditions Studied
Interventions
- BEHAVIORAL Accelerated Diagnostic Protocol Emergency Department Observational Unit
Study Locations (1)
Michigan
- William Beaumont Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2003-08 |
| Est. Completion | 2005-09 |
| Phase | NA |
What the finished NCT00321022 record still lists
NCT00321022 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 1,112-participant average among 7 other Transient Ischemic Attack trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Transient Ischemic Attack appearing as the primary indexed condition, and to 1 intervention - of which Accelerated Diagnostic Protocol Emergency Department Observational Unit is the first listed.
NCT00321022 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00321022 about?
NCT00321022 is a clinical study titled "Transient Ischemic Attack (TIA) Accelerated Diagnostic Protocol". The primary objective of this study is to determine if emergency department patients with Transient Ischemic Attack (TIA) that are managed using a TIA "accelerated diagnostic protocol", or "ADP", demonstrate a significant decrease in their index visit length of stay and cost, with comparable diagnos...
What is the current status of trial NCT00321022?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2003-08. Estimated completion is 2005-09.
What conditions does trial NCT00321022 study?
This clinical trial studies the following conditions: Transient Ischemic Attack.
What interventions are being tested in trial NCT00321022?
The interventions under investigation include: Accelerated Diagnostic Protocol Emergency Department Observational Unit (BEHAVIORAL).
Who is sponsoring clinical trial NCT00321022?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00321022 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transient Ischemic Attack
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
COMPLETED · NA
-
Comprehensive Post-Acute Stroke Services
COMPLETED · NA
-
Reducing Stroke Risk in African-American Men
COMPLETED · NA
-
GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients
COMPLETED · NA
-
Center for Stroke Disparities Solution - Community Transitions Intervention
COMPLETED · NA
-
Florida Cerebrovascular Disease Biorepository and Genomics Center
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia